Mrs. Janice Marie De Smidt, MA CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 5595 County Road Z, West Bend, WI 53095 Phone: 262-306-2100 Fax: 262-306-2151 |
Lindsey Hamann, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5595 County Road Z, West Bend, WI 53095 Phone: 262-306-2100 |
Mrs. Tammy Nicole Salas, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 540 Shepherds Dr, West Bend, WI 53090 Phone: 262-306-8540 Fax: 262-306-8451 |
Larissa Lillian Lafavor Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1700 W Paradise Dr, West Bend, WI 53095 Phone: 262-334-3451 |
Rachael Beth Reynolds, MS. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1315 Royal Dr, West Bend, WI 53090 Phone: 305-725-9300 |
Erin Kelley Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2130 Continental Dr, West Bend, WI 53095 Phone: 877-407-3422 Fax: 877-407-4329 |
News Archive
A Mississippi State University researcher is developing new miniature models to better understand the factors that lead to heart disease and sickle cell anemia.
Accera, Inc., a biotech company specializing in cognitive health, announced today that it has identified the genetic profile of Alzheimer's disease (AD) patients who have a high probability of responding to Axona (AC-1202), a prescription medical food product available at pharmacies nationwide.
Reginald C. Farrow and Zafer Iqbal, research professors at NJIT, were awarded a patent today for an improved method of fabricating arrays of nanoscale electrical probes. Their discovery may lead to improved diagnostic tools for measuring the spatial variation of electrical activity inside biological cells.
VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) candidates for the treatment of cancer, respiratory and inflammatory diseases, announced today the completion of a $25 million Series A Extension.
A study in Ireland found that women recovering from gynaecological cancer received little advice from healthcare professionals about the effects of the disease on sexuality. This was not as important in initial stages of diagnosis and treatment where patients were dealing with life and death issues.
› Verified 2 days ago